Status:
COMPLETED
Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH)
Lead Sponsor:
Korea University Guro Hospital
Conditions:
Total Laparoscopic Hysterectomy
Patient-controlled Analgesia
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the dual channel intravenous patient-controlled analgesia (IV-PCA) with single channel elastomeric pump (only one channel of dual channel pump is used for blind...
Detailed Description
The Bellomic® M silicone balloon infuser, dual continuous petite type (cebika, Uiwang-si, Gyeonggi-do, Republic of Korea) is a newly designed IV-PCA device that is a 2-channel infusion elastomeric pum...
Eligibility Criteria
Inclusion
- patient who was scheduled to undergo elective TLH under general anesthesia, was a female aged 19-75 years, and had an American Society of Anesthesiologists physical status I-II
Exclusion
- body mass index \> 30.0 kg/m2, known hypersensitivity to the drugs used in this study, significant liver or renal dysfunction, or a history of drug abuse or dependence, recent major procedure or surgery, or preoperative analgesic use
Key Trial Info
Start Date :
September 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04082039
Start Date
September 3 2019
End Date
October 30 2020
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesiology and Pain Medicine, Korea University Guro Hospital
Seoul, South Korea, 08308